Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Change in Acquisitions & Divestments (2020 - 2025)

Historic Change in Acquisitions & Divestments for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to $19.7 million.

  • Bolt Biotherapeutics' Change in Acquisitions & Divestments fell 4732.26% to $19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.0 million, marking a year-over-year decrease of 4964.99%. This contributed to the annual value of $146.3 million for FY2024, which is 3805.92% down from last year.
  • According to the latest figures from Q3 2025, Bolt Biotherapeutics' Change in Acquisitions & Divestments is $19.7 million, which was down 4732.26% from $25.3 million recorded in Q2 2025.
  • In the past 5 years, Bolt Biotherapeutics' Change in Acquisitions & Divestments registered a high of $117.5 million during Q1 2022, and its lowest value of $3.8 million during Q2 2021.
  • Over the past 5 years, Bolt Biotherapeutics' median Change in Acquisitions & Divestments value was $37.4 million (recorded in 2024), while the average stood at $40.3 million.
  • In the last 5 years, Bolt Biotherapeutics' Change in Acquisitions & Divestments surged by 187086.86% in 2021 and then crashed by 5616.49% in 2025.
  • Bolt Biotherapeutics' Change in Acquisitions & Divestments (Quarter) stood at $51.3 million in 2021, then dropped by 18.14% to $42.0 million in 2022, then increased by 14.29% to $48.0 million in 2023, then crashed by 46.88% to $25.5 million in 2024, then fell by 22.8% to $19.7 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $19.7 million for Q3 2025, versus $25.3 million for Q2 2025 and $14.6 million for Q1 2025.